Weekly GLP-1RAs Compared for Type 2 Diabetes (FREE)

By Kelly Young Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Dulaglutide, once-weekly exenatide, and taspoglutide are associated with the largest reductions in hemoglobin A1c among all the weekly glucagon-like peptide-1 receptor agonists (GLP-1RAs), according to a network meta-analysis …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news